Light-Activated Drug Unclogs Blocked Arteries
Atherosclerosis is the accumulation of fatty plaque in arteries, a major cause of heart attack and stroke. A group of researchers at Stanford University has discovered that a drug commonly used in cancer therapy may be effective in partially dissolving blockages.
Only a few types of cells absorb the drug lutetium texaphyrin. These include cancer cells and a cell that plays a role in the formation of plaque. The cells die only after exposure to high-intensity red light.
The researchers injected lutetium texaphyrin in 16 patients who had blocked leg arteries. A day later they delivered red light through a fiber optic probe, inserted into a small slit in the artery. After four weeks, 12 of the 16 patients experienced a noticeable reduction in plaque deposits.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024